These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 32833793)
21. [Biomarkers of the development and progression of diabetic polyneuropathy]. Karakulova YV; Filimonova TA Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):70-75. PubMed ID: 32929927 [TBL] [Abstract][Full Text] [Related]
22. Identification and quantification of nociceptive Schwann cells in mice with and without Streptozotocin-induced diabetes. Hu X; Agarwal N; Zhang MD; Ernfors P; Kuner R; Nyengaard JR; Karlsson P J Chem Neuroanat; 2022 Sep; 123():102118. PubMed ID: 35680105 [TBL] [Abstract][Full Text] [Related]
23. Painful and painless diabetic neuropathy: one disease or two? Spallone V; Greco C Curr Diab Rep; 2013 Aug; 13(4):533-49. PubMed ID: 23677582 [TBL] [Abstract][Full Text] [Related]
26. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Rolim LC; da Silva EM; Flumignan RL; Abreu MM; Dib SA Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011265. PubMed ID: 31201734 [TBL] [Abstract][Full Text] [Related]
27. The reduction of intraepidermal P2X Bechakra M; Schüttenhelm BN; Pederzani T; van Doorn PA; de Zeeuw CI; Jongen JLM J Comp Neurol; 2017 Dec; 525(17):3757-3768. PubMed ID: 28815599 [TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes. Cheng HT; Dauch JR; Hayes JM; Yanik BM; Feldman EL Neurobiol Dis; 2012 Jan; 45(1):280-7. PubMed ID: 21872660 [TBL] [Abstract][Full Text] [Related]
29. Association between small fiber neuropathy and higher skin accumulation of advanced glycation end products in patients with type 1 diabetes. Araszkiewicz A; Gandecka A; Nowicki M; Uruska A; Malińska A; Kowalska K; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D Pol Arch Med Wewn; 2016 Nov; 126(11):847-853. PubMed ID: 27906877 [TBL] [Abstract][Full Text] [Related]
30. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. Kluding PM; Pasnoor M; Singh R; Jernigan S; Farmer K; Rucker J; Sharma NK; Wright DE J Diabetes Complications; 2012; 26(5):424-9. PubMed ID: 22717465 [TBL] [Abstract][Full Text] [Related]
31. Abnormal LDIflare but normal quantitative sensory testing and dermal nerve fiber density in patients with painful diabetic neuropathy. Krishnan ST; Quattrini C; Jeziorska M; Malik RA; Rayman G Diabetes Care; 2009 Mar; 32(3):451-5. PubMed ID: 19074993 [TBL] [Abstract][Full Text] [Related]
32. Structural Nerve Remodeling at 3-T MR Neurography Differs between Painful and Painless Diabetic Polyneuropathy in Type 1 or 2 Diabetes. Jende JME; Groener JB; Kender Z; Rother C; Hahn A; Hilgenfeld T; Juerchott A; Preisner F; Heiland S; Kopf S; Nawroth P; Bendszus M; Kurz FT Radiology; 2020 Feb; 294(2):405-414. PubMed ID: 31891321 [TBL] [Abstract][Full Text] [Related]
33. The cutaneous nerve biopsy: technical aspects, indications, and contribution. Mellgren SI; Nolano M; Sommer C Handb Clin Neurol; 2013; 115():171-88. PubMed ID: 23931780 [TBL] [Abstract][Full Text] [Related]
34. Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy. Karlsson P; Gylfadottir SS; Kristensen AG; Ramirez JD; Cruz P; Le N; Shillo PR; Tesfaye S; Rice ASC; Tankisi H; Finnerup NB; Nyengaard JR; Jensen TS; Bennett DLH; Themistocleous AC Diabetologia; 2021 Apr; 64(4):923-931. PubMed ID: 33483760 [TBL] [Abstract][Full Text] [Related]
35. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Gandhi RA; Marques JL; Selvarajah D; Emery CJ; Tesfaye S Diabetes Care; 2010 Jul; 33(7):1585-90. PubMed ID: 20587724 [TBL] [Abstract][Full Text] [Related]
36. Insulin Treatment Attenuates Small Nerve Fiber Damage in Rat Model of Type 2 Diabetes. Andreasen LJ; Kirk RK; Fledelius C; Yorek MA; Lykkesfeldt J; Akerstrom T J Diabetes Res; 2020; 2020():9626398. PubMed ID: 32832565 [TBL] [Abstract][Full Text] [Related]
37. A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathy. Scholz J; Rathmell JP; David WS; Chad DA; Broderick AC; Perros SG; Shin NS; Wells JL; Davis JB; DiMaggio CJ; Wang S; Tate SN Pain; 2016 Oct; 157(10):2297-2308. PubMed ID: 27322439 [TBL] [Abstract][Full Text] [Related]
38. Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain. Raputova J; Rajdova A; Vollert J; Srotova I; Rebhorn C; Üçeyler N; Birklein F; Sommer C; Vlckova E; Bednarik J Eur J Pain; 2022 Nov; 26(10):2198-2212. PubMed ID: 36069121 [TBL] [Abstract][Full Text] [Related]
39. NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes. Ponirakis G; Odriozola MN; Odriozola S; Petropoulos IN; Azmi S; Ferdousi M; Fadavi H; Alam U; Marshall A; Jeziorska M; Miro A; Kheyami A; Tavakoli M; Al-Ahmar A; Odriozola MB; Odriozola A; Malik RA Diabetes Technol Ther; 2016 Dec; 18(12):800-805. PubMed ID: 27922760 [TBL] [Abstract][Full Text] [Related]
40. Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy. Hu X; Buhl CS; Sjogaard MB; Schousboe K; Mizrak HI; Kufaishi H; Jensen TS; Hansen CS; Yderstræde KB; Zhang MD; Ernfors P; Nyengaard JR; Karlsson P Diabetologia; 2023 Dec; 66(12):2332-2345. PubMed ID: 37728731 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]